Ad is loading...
MYITX
Price
$7.77
Change
-$0.02 (-0.26%)
Updated
Nov 15 closing price
VTPSX
Price
$129.64
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

MYITX vs VTPSX

Header iconMYITX vs VTPSX Comparison
Open Charts MYITX vs VTPSXBanner chart's image
NYLI WMC International Research Eq Cl A
Price$7.77
Change-$0.02 (-0.26%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Idx InstlPls
Price$129.64
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
MYITX vs VTPSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MYITX vs. VTPSX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYITX is a Buy and VTPSX is a Buy.

FUNDAMENTALS
Fundamentals
VTPSX has more cash in the bank: 442B vs. MYITX (201M). VTPSX pays higher dividends than MYITX: VTPSX (3.30) vs MYITX (1.69). MYITX was incepted earlier than VTPSX: MYITX (17 years) vs VTPSX (14 years). MYITX has a lower initial minimum investment than VTPSX: MYITX (15000) vs VTPSX (100000000). MYITX annual gain was more profitable for investors over the last year : 14.19 vs. VTPSX (10.92). MYITX (16.63) and VTPSX (15.93) have equivalent 5 years return.
MYITXVTPSXMYITX / VTPSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years14 years-
Gain YTD7.6184.537168%
Front LoadN/AN/A-
Min. Initial Investment150001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets201M442B0%
Annual Yield % from dividends1.693.3051%
Returns for 1 year14.1910.92130%
Returns for 3 years0.12-5.85-2%
Returns for 5 years16.6315.93104%
Returns for 10 years5.5629.9219%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LYG2.830.07
+2.54%
Lloyds Banking Group PLC
WABC57.030.17
+0.30%
Westamerica Bancorporation
FBIZ49.82-0.11
-0.22%
First Business Financial Services
W38.22-0.57
-1.47%
Wayfair
CARM0.88-0.06
-5.93%
Carisma Therapeutics